Pharmacokinetics of Single and Multiple Doses of Omega‐3 Carboxylic Acids in Healthy Chinese Subjects: A Phase I, Open‐Label Study-Reference-Cited by-同舟云学术

Pharmacokinetics of Single and Multiple Doses of Omega‐3 Carboxylic Acids in Healthy Chinese Subjects: A Phase I, Open‐Label Study

Published:2020-06-21 Issue:8 Volume:9 Page:985-994
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

Jing Shan¹,Zhang Zhenxian²,Chen Xiaowen²,Miao Rui²,Nilsson Catarina³,Lin Yang¹

Affiliation:

1. Clinical Pharmacology Centre Beijing Anzhen Hospital Capital Medical University Beijing China

2. R&D China AstraZeneca Shanghai China

3. Quantitative Clinical Pharmacology Early Clinical Development AstraZeneca Research and Development Gothenburg Sweden

Funder

AstraZeneca

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.800

Reference18 articles.

1. Centers for Disease Control and Prevention. Heart disease facts.https://www.cdc.gov/heartdisease/facts.htm. Published November 2017. Accessed August 20 2019.

2. Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease

3. Increased residual cardiovascular risk in patients with diabetes and high versus normal triglycerides despite statin-controlled LDL cholesterol

4. Expert consensus on hypertriglyceridemia and its cardiovascular risk management;China Cholesterol Education Planning Committee;Chin J Cardiol,2017

5. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic Comparison Between a Fixed-Dose Combination of Atorvastatin/Omega-3-Acid Ethyl Esters and the Corresponding Loose Combination in Healthy Korean Male Subjects;Drug Design, Development and Therapy;2024-02

2. Pharmacokinetics of Icosapent Ethyl: An Open‐Label, Multiple Oral Dose, Parallel Design Study in Healthy Chinese Subjects;Clinical Pharmacology in Drug Development;2022-07-03

3. Formation of Self-Assembled Liquid Crystalline Nanoparticles and Absorption Enhancement of Ω-3s by Phospholipids and Oleic Acids;Pharmaceutics;2021-12-28